Clinical trials play a pivotal role in advancing our understanding and treatment of Alzheimer’s Disease and dementia. These trials focus on testing new medications, therapies, and interventions aimed at improving symptoms, slowing disease progression, or preventing onset. They involve diverse participant recruitment to ensure findings are applicable across different groups. Researchers rigorously evaluate safety, efficacy, and potential side effects of experimental treatments. Participation not only offers access to cutting-edge care but also contributes to scientific knowledge crucial for future advancements. By testing new approaches, these trials are instrumental in the ongoing pursuit of effective treatments and, ultimately, a cure for Alzheimer’s Disease and various types of dementia.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China